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Marion duPont Scott Equine Medical Center, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Leesburg, VA, USA
Objectives: To determine the outcome of treating distal interphalangeal joint collateral
ligament (DIJCL) desmopathy using magnetic resonance imaging (MRI)-guided ligament
injection.
Methods: Medical records of 13 adult horses diagnosed with DIJCL desmopathy
using low-field MRI and treated by MRI-guided ligament injection of mesenchymal stem
cells and/or platelet-rich plasma (PRP) were reviewed. Information collected included
signalment, MRI diagnosis, treatment type, time to resolution of lameness, and level of
exercise after treatment.
results: Collateral ligament inflammation was diagnosed as a cause of lameness in 13
horses. MRI was used to guide the injection of the injured DIJCL. All lameness attributed
to DIJCL desmopathy resolved with the resulting level of performance at expected (10)
or less than expected (3).
conclusion and clinical relevance: Injection of the DIJCL can be safely completed
in horses standing in a low-field magnet guided by MRI as previously demonstrated in
cadaver specimens. The positive response in all horses suggests that administration of
stem cells or PRP along with rest and appropriate shoeing may be a safe and useful
treatment for DIJCL desmopathy.
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inTrODUcTiOn
Treatment of tendon and ligament injuries by injection with either mesenchymal stem cells (MSC) 
or platelet-rich plasma (PRP) is reported to improve healing and eventual outcome (1, 2). These 
techniques have been used in tendons and ligaments of the metacarpus and metatarsus, where 
ultrasound can be used to direct the injection (1). Resolution of tendon and ligament fiber disrup-
tion is often monitored using sequential ultrasonography, which indicates improved fiber structure 
following natural disease and experimentally created lesions (3, 4).
Magnetic resonance imaging (MRI) has recently identified and characterized tendon and 
ligament injuries in the horse’s foot as a cause of lameness (5–9). Characteristic MRI findings 
of desmopathy in the distal interphalangeal joint collateral ligament (DIJCL) include ligament 
Abbreviations: DIJCL, distal interphalangeal joint collateral ligament; MRI, magnetic resonance imaging; MSC, mesenchymal 
stem cells; PRP, platelet-rich plasma; STIR FSE, short-tau inversion-recovery fast spin echo sequence; T1W-GE, T1-weighed 
gradient echo sequence.
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enlargement, changes in border definition, and increased signal 
intensity within the ligament (10). These changes correspond 
to degenerative changes observed histologically, including col-
lagen degeneration, fissure formation, and fibrocartilaginous 
metaplasia, and are often accompanied with osseous change in 
the ligament insertion (10, 11).
Treatments for tendon and ligament injury in the foot include 
rest, anti-inflammatory treatment, including intra-synovial 
injection of corticosteroids, hyaluronic acid, interleukin receptor 
antagonist,1 supportive shoeing, and shockwave treatment (12, 
13). Newer approaches to treat tendons and ligaments using 
regenerative medicine therapies include PRP and MSC therapy (2, 
14, 15). PRP injection improved the ultrasonographic appearance 
and organization of the linear fiber pattern in a surgical model 
of superficial digital flexor tendon injury (16). Bone marrow-
derived MSC treatment improved histological signs of healing 
and structural organization in a collagenase model of superficial 
digital flexor tendon injury (4). A large retrospective study look-
ing at MSC therapy for superficial digital flexor tendon injury in 
National Hunt racehorses in the United Kingdom reported an 
82% long-term success rate (2).
Application of regenerative therapies to DIJCL lesions is 
 limited due to limited access in the foot. Although ultrasonog-
raphy, radiography, or computed tomography may assist in 
 localizing these therapies to lesions within the foot, each tech-
nique has distinct disadvantages. Ultrasonography gives a limited 
view of the DIJCL, and lesions diagnosed by MRI have been seen 
at the distal insertion, where the ligament cannot be seen ultra-
sonographically (10, 11). Radiography can assist placement of a 
needle in the expected area of the lesion; however, the ligament 
and lesion are not visible, making this a blind technique relying 
on anatomic understanding rather than direct visualization (17). 
Computed tomography with contrast enhancement can be used 
to specifically locate the site for injection; however, this must be 
performed under general anesthesia and does not offer detection 
of new fluid at the injection site postinjection (18).
Magnetic resonance imaging-guided techniques used success-
fully in human medicine for biopsies and treatment of tumors 
(19, 20). Recently, a technique of using MRI to guide injection 
of the DIJCL was developed and validated in horse feet from 
cadavers (21). We hypothesized that naturally occurring lesions 
in the DIJCL within the hoof can be accurately injected via MRI 
guidance in the standing horse. Additionally, we hypothesized 
that the injection technique would not compromise healing of 
the DIJCL healing.
MaTerials anD MeThODs
animals
Client-owned horses with unilateral lameness localized to the 
hoof via diagnostic nerve blocks were admitted to the Marion 
duPont Scott Equine Medical Center at the Virginia-Maryland 
College of Veterinary Medicine. All horses included in the study 
had moderate-to-severe uniaxial DIJCL desmopathy. When 
affected ligaments had evidence of severe injury or previous 
1 IRAP II, Arthrex Vet Systems, Naples, FL, USA 
treatments such as rest, anti-inflammatory treatments, and cor-
rective shoeing were not successful, ligament injection using MRI 
guidance was offered as a treatment. Either MCS combined with 
PRP or PRP alone was selected for injection based on the clini-
cian’s preference and cost to the client.
Diagnostic Magnetic resonance imaging
The diagnosis of DIJCL lesions associated with foot lameness was 
made using a 27-T magnet2 with horses in a standing position 
using a hoof coil (see text footnote 2). The MRI examination of 
the feet was completed, as previously described, using proton 
density-weighted spin echo, T1-weighed gradient echo sequence 
(T1W-GE), T2-weighted fast spin echo, and short-tau inversion-
recovery fast spin echo sequence (STIR FSE) sequences (22). 
Proton density-weighted spin echo scans were completed in 
a transverse plane; T1W-GE scans in transverse, frontal, and 
sagittal planes; T2-weighted fast spin echo scans in dorsal and 
transverse planes and STIR FSE scans in transverse, dorsal, and 
sagittal planes.
Preparation of Platelet rich Plasma
Blood (450 ml) was aseptically collected in citrate–phosphate–
dextrose–adenine anticoagulant from each patient for PRP 
processing. Blood was then processed to produce 12 ml of PRP 
(5- to 7-fold increase in platelets with 0.02- to 0.05-fold white 
blood cells) via centrifugation.
Preparation of Mesenchymal stem cells
Bone marrow aspirate (n = 7) was collected aseptically from the 
patient’s left tuber coxa or mid sternum, as previously described 
(23). In brief, heparinized bone marrow was collected from the 
patient, the aspirate was centrifuged and cultured in low-glucose 
Dulbecco’s Modified Eagle Medium supplemented with 10% 
fetal bovine serum, 300 μg of l-glutamine/ml, 100 U of sodium 
penicillin, and 100 μg of streptomycin sulfate/ml at 37°C in a 5% 
carbon dioxide atmosphere with 90% humidity for media sup-
plementation every 48 h. Cells were passaged at 80% confluence, 
and passage 1 or 2 was used for injection. Once adequate cells 
were prepared, the injection was scheduled, and on the day of 
injection, cells were trypsinized, washed with phosphate buffer 
solution four times, and suspended in autologous PRP for injec-
tion (5 million cells/ml).
Mri-guided injection
Local anesthesia of the digital nerves was completed at the level 
of the proximal sesamoid bones. Sedation for the procedure 
was predominately titration of intravenous detomidine and 
butorphanol used during routine MRI examinations of the 
feet and as needed to prevent movement of the horse. Aseptic 
preparation and wrapping of the injection site were completed 
prior to putting the limb in the magnet. T1W-GE and STIR 
FSE sequences were completed prior to injection. Injection of 
each DIJCL was completed using a 16-gauge intravenous cath-
eter over a needle (3 cases) or a 16-gauge non-ferromagnetic 
2 Hallmarq Veterinary Imaging Inc., Acton, MA, USA
FigUre 1 | (a) With the horse’s left foot in the magnet the needle was placed using T1W-GE sequences to direct the needle into the medial DIJCL. (B) T1-weighted 
gradient echo sequence in this horse’s foot (medial is to the left) with focal hypointense signal (arrow) from the titanium needle placement in the DIJCL.
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(titanium) needle3 (10 cases) designed for biopsy guided by 
MRI. The needle placement utilized the previously described 
technique (21). Briefly, needle insertion was at a point between 
the common digital extensor tendon and the dorsal edge of 
the collateral cartilage and directed perpendicular to the solar 
surface (Figure 1). Injections were well tolerated by the horses, 
and there was no evidence that the horse had any sensation 
during the injection. Firm resistance was present as the nee-
dle penetrated the ligament. The needle was inserted until it 
was in contact with the coffin bone. There was resistance to 
injection until the needle was withdrawn a few millimeters. 
T1-weighted gradient echo sequences were repeated as the 
needle was advanced identifying the position of the needle and 
allowing for any needed correction of its position. In the first 
three cases, 16-gauge catheter was used with its needle inserted 
and the needle withdrawn once the catheter was in position. 
Catheter removal was sometimes necessary, and a new catheter 
redirected into the target. Subsequently, a series of progressive 
scans was devised to slowly advance a titanium needle, while 
correcting the angle using the sequential scans as the needle 
was placed in real-time (see text footnote 2). Once, in place, the 
stylet was withdrawn from the needle, and 1–2 ml of PRP or 
MSC suspended in PRP was injected. Postinjection transverse 
STIR FSE sequences were completed in an attempt to docu-
ment increased fluid signal in the DIJCL.
3 Puncture needle, Invivo, Gainesville, FL, USA
rehabilitation
Postinjection recommendations included absolute stall rest for 
1 month with subsequent increased exercise by walking in hand 
for 2 months and bar shoe application to both front feet. Turnout 
was not recommended until walking and trotting under saddle 
was completed without evidence of lameness.
Outcome Measures
Follow-up was completed by contacting owners by telephone, 
email, or by examination 1  year or longer after the injection. 
Information requested at the time of follow-up included whether 
the horse was sound, and whether the level of exercise was as 
expected or less than expected (Table  1). A recheck MRI was 
completed in four horses to evaluate any change in the MRI 
abnormalities.
resUlTs
Signalment, duration and grade of lameness, type of treatment, 
and outcome are presented in Table 1. All horses were referred, 
and all had a history of lameness localized to the foot. Lameness 
resolved with a palmar digital nerve block in three horses, with 
an abaxial sesamoid block in four horses, up to a low four-point 
block in one horse and a history of lameness localized to the foot 
without specifying the nerve block in five horses. One horse had 
evidence of injury to the collateral ligament on a previous ultra-
sound examination. Ten horses had no resolution of the lameness 
TaBle 1 | Mri-guided injection of the DiJcl.
horse # age 
(years)
sex Breed grade of 
lameness  
prior to 
injection
Duration of 
lameness prior 
to injection 
(months)
Type of 
injection
level of exercise: 
expected or less 
than expected
Time to 
resolution 
of lameness 
(months)
Other Mri 
lesions
Treatments 
after injection
1 11 G Wmbld 2/5 4 Stem cells 
and PRP
Expected ~8 NB cyst Unk
2 7 M Wmbld X 3/5 1 Stem cells 
and PRP
Expected 12 Associated  
with DP  
fracture
Unk
3 10 G Cleveland 
Bay
3/5 4 PRP Expected 8 None Unk
4 9 G Selle Fran NR 3 PRP Lesser Unk Mild NB  
edema
None
5 8 F Draft X 3/5 1 Stem cells 
and PRP
Expected 6 Mild coffin bone 
edema
Unk
6 17 Swedish 
Wmbld
NR 6 PRP Expected 18 None None
7 5 G ISH NR 3 PRP Expected 7 Navicular  
bursitis and  
DIJ synovitis
None
8 14 G TB X 3/5 3 Stem cells 
and PRP
Sound not  
in full work
6 Bilateral  
navicular  
bone edema
Hyaluronic acid in 
the DIJ
9 7 G TB 2/5 12 PRP Expected 7 Navicular  
bursitis
Triamcinolone in 
the navicular bursa
10 10 G Dutch Wmbld 3/5 12 Stem cells 
and PRP
Expected 8 None None
11 16 G Crossbred 3/5 8 PRP Expected 6 None Unk
12 11 G TB 2/5 8 Stem cells 
and PRP
Lesser 6 None Unk
13 19 G Irish Wmbld NR NR Stem cells 
and PRP
Lesser >18 None Stem cells in 
the DIJ and 
Shockwave
G, gelding; F, female; M, male; Wmbld, Warmblood; ISH, Irish sport horse; TB, thoroughbred; PRP, platelet-rich plasma; DP, distal phalanx; DIJ, distal interphalangeal joint; MCS, 
mesenchymal stem cells; NR, not recorded; Ukn, unknown.
4
White and Barrett Collateral Ligament Desmitis Treatment
Frontiers in Veterinary Science | www.frontiersin.org September 2016 | Volume 3 | Article 73
after previous treatments, including variable periods of rest, 
intra-articular treatment of the affected distal interphalangeal 
joint with triamcinolone, and/or hyaluronic acid (seven), oral 
phenylbutazone administration (one), and intravenous disodium 
tiludronate (two). Based on the history of localization of the 
lameness to the foot and subsequent identification of injury to 
the DIJCL desmopathy of the DIJCL were considered the primary 
cause of lameness in 13 horses.
Abnormal MRI signal was found in T1W-GE (9), STIR (7), 
T2 FSE (12), and PD (11) sequences. Images from one horse 
were not available to evaluate all sequences. Five horses had 
DIJCL insertion fossa enlargement, one had cyst formation at 
the insertion, and one had focal bone inflammation at the inser-
tion. Desmopathy in the horse with hind limb desmopathy was 
associated with a previous distal phalanx fracture, which affected 
the collateral ligament at its insertion.
Two horses had two 500  mg doses of flunixin meglumine 
postinjection, while the remaining horses had no postinjection 
treatment. No complications after the DIJCL injections were 
reported. All lameness due to injuries of the DIJCLs resolved. The 
time for resolution of the lameness ranged from 6 to 18 months 
(Table 1). Four horses had follow-up MRI examinations, which 
revealed a partial (two) or complete (two) resolution of the 
abnormal signal (Figure 2). The presence of improved but still 
abnormal signal in follow-up MRI examinations of two horses 
could not be specifically identified as a response to the needle 
insertion.
Lameness in one horse due to DIJCL desmopathy, navicular 
bone edema, and navicular bursitis recurred. Repeat MRI 
3 months after the initial diagnosis showed marked improvement 
in the injected collateral ligament, but navicular bone edema and 
bursitis were unchanged. Lameness resolved with injection of the 
navicular bursa, but subsequently the horse was retired due to 
recurring front limb lameness. Lameness in the affected limb in 
one horse resolved, but the horse was subsequently retired due to 
rear limb lameness.
DiscUssiOn
Surgical and medical intervention for tendon and ligament 
injuries has been used for many decades. The goal is to stimulate 
a healing in an environment, which heals with scar tissue or 
does not heal due to vascular compromise (24). Lesions found 
in an injured DIJCL and deep digital flexor tendon consist of 
disorganized matrix and poor collagen maturation (6, 10, 25). 
The inability of some of these lesions to resolve may be due to a 
lack of inflammatory response and/or lack of blood supply with 
no stimulus for fiber regeneration or remodeling.
FigUre 2 | (a) Abnormal hyperintense signal (arrow) in a DIJCL prior to injection (T2-weighted fast spin echo sequence; medial is to the left). (B) Recheck MRI 
examination demonstrating normal signal intensity (arrow) in the same DIJCL 6 months after injection (T2-weighted fast spin echo sequence; medial is to the left).
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Surgical splitting of tendon and ligament lesions is an attempt 
to release acute core lesion edema and is used to stimulate healing 
in avascular scar tissue in chronic injuries (24, 26). Because the 
needle can be accurately placed in the DIJCL using MRI guidance, 
this disruption of the abnormal tissue may stimulate a cellular 
response and increased vascularity in the ligament as observed 
with tendon and ligament splitting without the use of MSC or 
PRP. Although prolonged stall rest with appropriate shoeing has 
been successful in resolving lameness in up to 60% of horses with 
or without additional medical therapy (9), all horses in our study 
had prior rest, which was not successful in resolving the lameness 
prior to injection.
Needle placement in the DIJCL is improved using MRI guid-
ance compared with use of radiographs or ultrasound (21). The 
needle position is identified as focal decreased signal intensity 
in the tissue (Figure  1). The technique has been improved by 
use of overlapping two slice T1W-GE sequences, which can be 
completed in real time sequentially as the needle is advanced (see 
text footnote 2). This allows visualization of and redirection of 
the needle placement as it is being advanced into the ligament. 
Additionally, this decreases the time required for the injection 
and helps complete needle placement with minimal redirection. 
Use of navigational ultrasound imaging, which can correlate pre-
vious MRI images with ultrasound for real-time guidance during 
interventional therapies, may provide an additional method for 
injection of the DIJCL (27). This appears to be an advantage for 
lesions identified by high-field MRI that can subsequently be 
treated without general anesthesia. However, it is not clear if this 
technique will allow accurate injection in the distal DIJCL, where 
ultrasound cannot penetrate the hoof.
Response to rest and corrective shoeing for DIJCL injuries 
is reported at 5 of 17 horses (29%) returning to full work with 
an additional 2 horses improved for light work and breeding 
(8). Rest, medical treatment, and supportive shoeing resulted in 
60% resolution of lameness in horses with DIJCL desmopathy 
(9). Horses with DIJCL desmopathy commonly have concurrent 
changes in the navicular bone, deep digital flexor tendon, and 
impar desmopathy making it difficult to determine the source 
of pain (13, 28). Horses with deep digital flexor lesions detected 
by MRI have a worse prognosis that horses with other types of 
injury, including DIJCL desmopathy. Seven of the 13 horses 
in this study had concurrent lesions in the navicular bone (6) 
and distal phalanx (1). None of the horses in this group had 
deep digital flexor tendon lesions likely improving the chance 
of successful treatment (13). Although concurrent lesions in 
seven horses could have contributed to the lameness, the DIJCL 
changes seen on MRI were considered the primary problem, 
which required treatment based on the history and character of 
the lesions.
This study confirms the ability to accurately inject the DIJCL 
in standing horses using sedation and local anesthesia for low-
field MRI. Although the treatment appears beneficial, this study 
did not confirm efficacy, as there is no direct comparison for cases 
treated with rest, as previously reported (13, 28). Furthermore, 
there was no control for the potential stimulation created by 
needle placement alone.
cOnclUsiOn
Magnetic resonance imaging-guided injection of stem cells or 
PRP into the DIJCL is a safe and repeatable technique in standing 
horses. Further studies of regenerative medical therapy for the 
DIJCL are needed to confirm the benefit of this therapy.
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